Empagliflozin as treatment in glycogen storage disease type IB patients

Background: Glycogen Storage Disease Ib (GSD Ib) is a disease that associates both neutropenia and neutrophil dysfunction, thereby causing recurrent infections and inflammatory bowel disease (IBD). As of now, the standard treatment of these complications has been the administration of granulocyte-st...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	María Arbelo Rodríguez, Elena Márquez Mesa, Cristina Lorenzo González, Marina Gutiérrez Vilar, Loredana Arhip, Mónica Ruiz Pons, José Pablo Suárez Llanos
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2025-06-01
סדרה:	Molecular Genetics and Metabolism Reports
נושאים:	Glycogen storage disease type Ib Empagliflozin Neutropenia Neutrophil dysfunction SGLT2 inhibitors 1,5-andhydroglucitol
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2214426925000412
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!